the research Institute of the Ministry of defence today to begin clinical tests of a domestic vaccine against coronavirus. To check the unique of the drug seized 50 military volunteers, some of whom are doctors. All participants of the program have to spend two weeks in quarantine. Testing will help to determine how to develop effective and safe for humans.
50 volunteers who have agreed to be the first to experience the new vaccine arrived in the 48th Central research Institute of the defense Ministry, which together with the National research centre of epidemiology and Microbiology, Ministry of health to develop a drug that can cause a strong immunity to COVID-19.
that military scientists, in collaboration with civilian colleagues are leading this work, in the beginning of last week, the President reported to the head of the defense Ministry.
“At present the specialists of the Institute is finalizing preclinical studies for the experimental sample of vaccine. The completion of these works June 1, to complete a clinical study is planned before the end of July”, — reported Sergey Shoigu, Minister of defense of the Russian Federation.
And now, as Minister, preclinical testing completed. Now to the volunteers and medical staff will have a 14-day quarantine.
“it is Very important before the start of the study is to prevent the infection volunteers and medical staff that will be with them to be a new coronavirus infection,” said Yevgeny Kryukov, the head of the Main military clinical hospital named after academician N. N. Burdenko, member-correspondent of the Russian Academy of Sciences.
Among the 50 volunteers 10 — military doctors. The remaining soldiers-contract employees from various departments of the armed forces.
“We needed to select around 50 people who meet the study criteria, among which are: voluntary informed consent, absence of chronic diseases of soldiers, including cancer, blood, whiche can have a significant impact on the course on the interpretation of clinical studies results of clinical studies,” explained Yevgeny Kryukov, the head of the Main military clinical hospital named after academician N. N. Burdenko, member-correspondent of the Russian Academy of Sciences.
During the research will have to resolve two fundamental questions — how safe the drug is and whether it causes immunity to the coronavirus. Before you start working with people, scientists have thoroughly studied its effects on animals.
“Informed by experts 48 the Institute has been proven the efficacy and safety of this drug on large laboratory animals, and small monkeys and hamsters”, — said Sergey Borisevich, head of the 48th Central research Institute of the Ministry of defense of Russia, member-correspondent of the Russian Academy of Sciences.
Contribution to medicine of the 48th Central research Institute of the Ministry of defense is difficult to overestimate. For example, they studied and successfully tested a vaccine for Ebola, middle East respiratory syndrome, a universal influenza vaccine. Clinical studies of the vaccine from COVID-19 to be completed by the end of July.
